TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

These 5 Stocks Under $10 Could Explode Higher Soon
INVESTING

These 5 stocks under $10 could explode higher soon

  • By Roberto Pedone
  • Jan 12, 2017 1:18 PM EST
Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results
VIDEO

Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results

  • By Valerie Young
  • Jan 3, 2017 1:31 PM EST
Inotek Pharma Glaucoma Drug Suffers Study Setback at Start of New Year
STOCKS

Inotek Pharma glaucoma drug suffers study setback

  • By Adam Feuerstein
  • Jan 3, 2017 8:42 AM EST
17 Thoughts on Biotech Stocks to Kick Off 2017
STOCKS

17 thoughts on biotech stocks to kick off 2017

  • By Adam Feuerstein
  • Jan 3, 2017 6:35 AM EST
Exact Sciences in Talks to Buy Genomic Health - Report
STOCKS

7 stocks under $10 making big moves higher

  • By Roberto Pedone
  • Sep 15, 2016 6:06 AM EDT
Valeant Isn't Out of Trouble Yet, Debt Remains Difficult to Curb
STOCKS

Beleaguered valeant appoints lead independent director

  • By Sarah Pringle
  • Jun 15, 2016 4:23 PM EDT
Valeant's Share Price Tumbles, Even as Papa Reiterates Plans for Divestitures
INVESTING

Government probes for Valeant; new board members put forth

  • By Ronald Orol
  • Apr 29, 2016 1:38 PM EDT
Valeant Acquires Eyegate Licensing Rights
OPINION

8 biotech stocks under $10 making big moves higher

  • By Roberto Pedone
  • Mar 20, 2016 9:50 AM EDT
JPMorgan’s Top 4 Oversold Pharma Stocks for Patient Investors
OPINION

Buy These 5 Stocks Now to Catch the Breakouts

  • By Roberto Pedone
  • Dec 11, 2015 10:11 AM EST
The Shorts Are Getting Squeezed Hard in Triumph Group
OPINION

5 Stocks Ready to Break Out Higher

  • By Roberto Pedone
  • Oct 30, 2015 10:58 AM EDT
Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate
OPINION

4 Stocks Spiking on Unusual Volume

  • By Roberto Pedone
  • Jul 27, 2015 2:39 PM EDT
Cramer: Biogen's Horseman May Have Fallen Off, I Like Others More
VIDEO

Cramer: Biogen's Horseman May Have Fallen Off, I Like Others More

  • By Jim Cramer
  • Jul 24, 2015 12:32 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.